Column chromatography remains one of the most versatile purification strategies in pharmaceutical research, medicinal chemistry, natural product isolation, impurity enrichment, and specialty chemical development. For drug discovery and development teams, the real challenge is not simply running a column—it is selecting the right stationary phase, solvent system, loading strategy, detection method, and fraction handling approach to recover valuable target compounds from complex mixtures with confidence. BOC Sciences provides comprehensive column chromatography services for small molecules, peptides, lipids, chiral compounds, impurities, reference materials, and structurally sensitive intermediates. Our scientists combine method screening, flash purification, preparative separation, orthogonal analytical confirmation, and scale-adaptable workflow design to help clients reduce purification uncertainty, protect scarce materials, and obtain well-characterized fractions for downstream synthesis, bioassay, structure elucidation, or formulation research.
BOC Sciences offers efficient flash column chromatography for rapid purification of synthetic intermediates, reaction mixtures, natural product fractions, and small molecule libraries where speed, recovery, and reproducibility are critical.
For mixtures requiring higher resolution, our preparative HPLC capabilities support targeted isolation of closely related analogs, positional isomers, degradation products, peptide fragments, and polar compounds that are difficult to resolve by open-column techniques.
Our custom purification services are designed for non-standard compounds, low-abundance targets, unstable molecules, and mixtures where routine chromatography does not provide sufficient separation.
We support impurity isolation and identification by enriching trace or co-eluting components from synthesis, degradation, fermentation, or extraction samples for structural investigation and comparative analysis.
BOC Sciences helps pharmaceutical and biotechnology teams isolate valuable compounds from complex mixtures through rational method design, scalable purification, and analytical confirmation.
Automated flash platforms enable rapid method translation from TLC or analytical scouting to practical purification. We use controlled gradients, optimized cartridge selection, and real-time detection to accelerate compound isolation while improving reproducibility across repeated purification runs.
Preparative LC is used when target compounds require higher chromatographic resolution than conventional flash methods can deliver. Our scientists refine gradient slope, injection loading, column chemistry, and fraction windows to isolate closely eluting components with strong recovery.
Purified fractions can be assessed using the BOC Sciences analytical platform, allowing chromatographic purity assessment, identity confirmation, and impurity comparison through complementary detection and characterization techniques.
For stereochemically complex programs, our chiral analysis and separation capabilities help resolve enantiomers and diastereomers using targeted stationary phase screening, mobile phase optimization, and fraction-level analytical comparison.
Charged molecules, salts, polar impurities, and ionic degradation products often require specialized chromatographic selectivity. We integrate ion chromatography testing and ion-exchange purification strategies to support difficult charged analytes.
When one chromatographic mode cannot resolve all components, we apply orthogonal selectivity using 2D chromatography testing concepts, combining different mechanisms to improve peak capacity and isolate hidden components.
BOC Sciences provides chromatography-based purification support for diverse pharmaceutical, biochemical, and specialty chemical samples. Our team adapts separation mode, column chemistry, solvent system, loading format, and fraction analysis according to compound structure, sample availability, target concentration, and downstream use.
Submit your crude mixture, target structure, chromatogram, or current purification challenge. Our scientists will design a chromatography strategy tailored to your compound properties and project objectives.
We review sample composition, target compound structure, available quantity, solubility, stability, previous chromatograms, and downstream use. This assessment determines whether flash chromatography, preparative HPLC, chiral separation, ion-exchange chromatography, or multi-step purification is most appropriate.
Our team screens stationary phases, mobile phases, modifiers, gradient profiles, sample loading formats, and detection conditions. For complex targets, we apply analytical method optimization to improve peak visibility and guide fraction collection.
The optimized method is transferred to the appropriate preparative format. We control loading, flow rate, gradient slope, detector response, and fraction windows to isolate target-rich fractions while minimizing co-elution, tailing, overload, and product loss.
Collected fractions are analyzed using suitable chromatographic and structural tools. We provide fraction maps, chromatographic profiles, method conditions, recovery observations, and practical recommendations for repeat purification, scale adjustment, or further characterization.
Co-elution is common when impurities share similar polarity, aromaticity, ionization behavior, or molecular size with the target compound. BOC Sciences addresses this challenge through orthogonal chromatography, modifier screening, shallower gradients, alternative stationary phases, and targeted fraction re-analysis. Our impurity profiling support helps reveal hidden components and improve collection decisions.
Scarce discovery compounds, natural product isolates, and advanced intermediates cannot tolerate unnecessary loss. We optimize sample loading solvent, cartridge compatibility, fraction window design, adsorption risk, evaporation conditions, and rinse strategy to improve target recovery. For fragile compounds, we avoid harsh solvent exposure and use compound-compatible concentration methods after collection.
A separation that works at analytical or small flash scale may fail when sample load increases. Through large scale separation planning, we evaluate column loading capacity, solvent consumption, peak broadening, pressure limits, fraction volume, and concentration burden to create a practical purification route for larger material needs.
Chiral molecules and structural isomers often require selectivity beyond standard silica or C18 methods. Our scientists apply chiral HPLC, specialty stationary phase screening, mobile phase modifier optimization, and fraction-level identity comparison to support enantiomeric enrichment, isomer isolation, and structure-activity exploration.
Collaborate with BOC Sciences to solve difficult separation problems, recover valuable target compounds, and establish practical chromatography workflows for discovery, synthesis, impurity research, and specialty molecule development.
Our teams combine analysis and purification experience across flash chromatography, preparative HPLC, ion-exchange, reversed-phase, normal-phase, and chiral separation, enabling a more complete response to complex sample behavior.
We do not force every sample into a single platform. Instead, we select practical chemical purification methods based on target structure, sample amount, matrix complexity, solubility, and downstream application.
Fractions can be checked by HPLC testing, UHPLC testing, LC-MS, and additional characterization tools to support confident pooling, comparison, and follow-up decision-making.
We provide clear method notes, chromatographic observations, fraction maps, and technical recommendations so medicinal chemists, process scientists, analytical teams, and project managers can understand how the purification was performed and how it may be repeated or adapted.
Client Needs: A medicinal chemistry group needed purification of a polar heteroaryl sulfonamide intermediate from a reaction mixture containing salts, unreacted amine, and two closely eluting side products. The compound was required for biological screening and follow-up analog synthesis.
Challenges: The target showed tailing on silica, weak retention under standard reversed-phase scouting, and partial degradation under prolonged acidic solvent exposure. Available crude material was limited, making repeated trial purification undesirable.
Solution: BOC Sciences performed parallel mini-column scouting across silica, amino, and reversed-phase cartridges, then selected a buffered reversed-phase gradient with mild modifier control. We tested six loading solvent ratios, collected 42 fractions, and used LC-MS-guided pooling to separate the target from salt-rich and amine-rich fractions while limiting exposure to harsh conditions.
Outcome: The project delivered a clean target fraction suitable for downstream assay preparation and provided a repeatable purification method for subsequent analog batches.
Client Needs: A biotech client requested isolation of the preferred enantiomer from a racemic bicyclic lactam scaffold used in a kinase-focused medicinal chemistry program. The client needed enough material for comparative biochemical and physicochemical evaluation.
Challenges: Initial achiral chromatography showed a single dominant peak, while early chiral screening produced broad peaks and unstable resolution. The target compound also had moderate solubility in common injection solvents.
Solution: We screened eight chiral stationary phases under normal-phase and polar-organic conditions, then refined alcohol modifier ratio, amine additive level, column temperature, and injection concentration. After selecting the best method, BOC Sciences executed repeated preparative injections and verified each collected fraction through enantiomeric purification HPLC/SFC-style analytical comparison before final pooling.
Outcome: The client received separated enantiomeric fractions with clear chromatographic differentiation and a practical method for future chiral resolution work.
Client Needs: A process development team needed isolation of a low-level oxidative impurity from a macrocyclic lactone intermediate. The impurity appeared inconsistently across batches and required enrichment for structural investigation.
Challenges: The impurity overlapped with the main component shoulder, represented a very small portion of the total mixture, and was sensitive to light and elevated temperature during concentration.
Solution: BOC Sciences first applied chromatography testing to map impurity behavior under acidic, neutral, and buffered mobile phases. We then used a two-stage workflow: large-load flash pre-fractionation followed by preparative HPLC heart-cut collection. More than 60 fractions were screened by LC-MS, and target-rich fractions were concentrated under low-temperature, light-protected conditions.
Outcome: The enriched impurity fraction supported further structural analysis and helped the client compare impurity formation across modified reaction and workup conditions.
Column chromatography is suitable for a wide range of drug discovery and development samples, including small molecules, intermediates, natural product extracts, peptide fragments, chiral compounds, and mixtures with closely related impurities. It helps clients isolate target components from complex matrices for structural confirmation, activity evaluation, route optimization, and scale-up studies. We tailor strategies such as normal phase, reverse phase, ion exchange, gel filtration, or preparative HPLC based on polarity, solubility, stability, and impurity profiles.
Method selection depends on the sample properties and project objectives. We evaluate the target compound and major impurities for polarity, retention behavior, solvent compatibility, detection method, and downstream handling. Small-scale screening identifies the optimal stationary phase, elution system, gradient, loading, and collection windows. For closely related compounds, we optimize flow rate, column efficiency, solvent strength, and detection to enhance selectivity and recovery. Method development typically starts at analytical scale before considering preparative scale adaptation.
Column chromatography addresses issues such as closely related impurities, isomer separation, complex natural product matrices, limited sample amounts, and scale-up reproducibility. By adjusting stationary phase, mobile phase, gradient, and fraction collection, we enhance separation. We combine TLC, HPLC, LC-MS, or UV monitoring for method iteration. For difficult separations, multidimensional strategies may be applied, such as initial rapid column separation followed by preparative HPLC or chiral columns for further refinement. Automation improves reproducibility and efficiency.
Yes, but scaling requires careful maintenance of critical separation parameters including column bed volume, linear velocity, sample load, gradient slope, solvent ratio, detection response, and fraction cutting. We design methods early with scale-up feasibility in mind. For gram-scale needs, column consistency, load assessment, fraction re-analysis, and solvent handling are optimized to balance yield, separation, and sample stability. Preparative LC systems and dedicated columns support transfer from analytical to preparative scales.
BOC Sciences integrates separation science with drug development requirements, not just performing an isolated step. We design chromatography schemes tailored to target molecules, focusing on sample recovery, impurity removal, reproducibility, downstream compatibility, and scalability. For early discovery, we deliver isolated fractions ready for structure confirmation and activity testing; for process development, we identify critical impurities, optimize separation pathways, and provide scale-up reference data, ensuring practical, high-quality outcomes for clients.
BOC Sciences did more than run a column. Their team reviewed our chromatograms, selected a better stationary phase, and returned a clear fraction map that our chemists could use immediately for the next synthesis cycle.
— Fleming, Senior Medicinal Chemist
Our compound was scarce and unstable, so recovery was our biggest concern. BOC Sciences optimized loading and pooling carefully, avoided unnecessary exposure, and helped us obtain material suitable for follow-up characterization.
— Marshall, Project Manager, Drug Discovery
We had struggled with broad peaks during internal chiral screening. Their scientists rapidly identified better selectivity and provided separated fractions with analytical confirmation that helped us move our stereochemistry study forward.
— Bryant, Lead Analytical Scientist
The final report was easy for both our chemistry and project teams to interpret. We received method conditions, fraction summaries, chromatograms, and practical recommendations for repeating the purification at larger scale.
— Duncan, Process Chemistry Director
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
